Dr. John Marshall proposes restructuring ASCO so that the primary presentation of new data occurs at smaller meetings and a synthesis of what has been learned over the year occurs at "big" ASCO. Medscape Hematology-Oncology
New research indicates that approximately 15% of patients with various myeloid malignancies have somatic mutations in TET2, a gene that appears to encode a tumor suppressor. Reuters Health Information
Focal cryoablation is minimally invasive but is as effective as more aggressive therapies in treating prostate cancer, and is associated with lower morbidity. Medscape Medical News
